What is continuous glucose monitoring (CGM) system? It is one that employs a tiny sensor which is inserted under the skin to check sugar levels in tissue fluid. This sensor stays in place for a week or several days after which it has to be replaced. Look for some improvement on this.
Through radio waves, a transmitter sends the data on blood glucose levels to a wireless monitor. This monitor is small and looks like a pager. The diabetic has to check the blood samples with a glucose monitor before programming the device.
These are more expensive than the traditional way of doing it but may help in better sugar control. They are FDA approved and give out real-time measurements displayed in one-minute or five-minute intervals. An alarm can be set to alert the user when the reading gets too low or too high.
The leading company for an insulin pump technology that one can wear is Insulet Corporation. Now this company has agreed to combine their wearable insulin pump with the continuous monitoring system of DexCom. What does this mean?
Combining the two will result in a handheld OmniPod System that will be wireless with Personal Diabetes Manager which can program the diabetic's delivery of insulin. It will display glucose readings continuously. The display will be glucose values that are real-time. In addition, this combo will alert the diabetics if the sugar levels are falling or rising.
Insulet Corporation's president and CEO, Duane DeSisto, said that this latest technology proves the company's dedication to improve the lives of the diabetics. Combining the DexCom's continuous monitoring system and making it into OmniPod Personal Diabetes Manager is easy to use and will prove the benefits of continuous monitoring and insulin pump therapy.
DexCom's president and CEO, Terrance H. Gregg, said his company is glad to work with Insulet Corporation in bringing about this combo that will make managing diabetes better for people with diabetes. The two technologies will certainly do that.
The combination of the two technologies will not only provide the diabetics with continuous data but also they will be able to track the trends that will make them know when to adjust their treatment. Alarms will sound off to alert the diabetics when their sugar levels are not within target levels.
The efforts to continue the development of this combo will go on through 2008 and should be ready to launch in the middle of 2009. Insulet Corporation's products for diabetes management will broaden as a result of this integration.